RBA
RMD icon

Richard Bernstein Advisors’s ResMed RMD Stock Holding History

Richard Bernstein Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-19,432
Closed -$3.77M – 325
2021
Q1 		$3.77M Hold
19,432
– – 0.09% 128
2020
Q4 		$4.13M Hold
19,432
– – 0.1% 115
2020
Q3 		$3.33M Hold
19,432
– – 0.09% 114
2020
Q2 		$3.73M Sell
19,432
-10,220
-34% -$1.67M 0.12% 96
2020
Q1 		$4.37M Sell
29,652
-11,582
-28% -$1.84M 0.16% 69
2019
Q4 		$6.39M Hold
41,234
– – 0.21% 62
2019
Q3 		$5.57M Hold
41,234
– – 0.18% 81
2019
Q2 		$5.03M Hold
41,234
– – 0.17% 89
2019
Q1 		$4.29M Buy
+41,234
New +$4.26M 0.14% 122

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Richard Bernstein Advisors's RMD Position: Q2 2021 in Review

Richard Bernstein Advisors sold out of ResMed (RMD) in Q2 2021, closing a stake of 19,432 shares — an estimated $3.77M sold.

Richard Bernstein Advisors first reported a position in RMD in Q1 2019 and held it in 9 quarters. The position peaked at $6.39M in Q4 2019. 661 funds tracked by Wall St. Rank hold RMD as of Q2 2021.

  • Richard Bernstein Advisors reported no remaining ResMed position as of Q2 2021 after selling out during the quarter.
  • Richard Bernstein Advisors sold 19,432 ResMed shares in Q2 2021, an estimated $3.77M.
  • Richard Bernstein Advisors first reported a position in ResMed in Q1 2019 and held it in 9 quarters.
  • Richard Bernstein Advisors's ResMed position peaked at $6.39M in Q4 2019.
  • 661 funds tracked by Wall St. Rank held ResMed as of Q2 2021.

Based on Richard Bernstein Advisors's 13F filing for Q2 2021, filed 5 Aug 2021.